Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study. (Record no. 18433072)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01184 a2200277 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515144724.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200811s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1523-6838 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1053/j.ajkd.2008.06.034 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Bleyer, Anthony J |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20081113 |
| 245 00 - TITLE STATEMENT | |
| Title | Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | American journal of kidney diseases : the official journal of the National Kidney Foundation |
| Date of publication, distribution, etc. | Nov 2008 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1024; author reply 1025 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Letter; Comment |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Acetates |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Calcium Compounds |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chelating Agents |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hyperphosphatemia |
| General subdivision | prevention & control |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Polyamines |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sevelamer |
| 773 0# - HOST ITEM ENTRY | |
| Title | American journal of kidney diseases : the official journal of the National Kidney Foundation |
| Related parts | vol. 52 |
| -- | no. 5 |
| -- | p. 1024; author reply 1025 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1053/j.ajkd.2008.06.034">https://doi.org/10.1053/j.ajkd.2008.06.034</a> |
| Public note | Available from publisher's website |
No items available.